4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosylpiperidine, 95%, 1g

1-Boc-Piperidin-2-ylpropionic acid, 95.0%, 1g

(4-Chlorobenzyl)(methyl)sulfane, 98%, 250mg

3-(4-(tert-Butoxycarbonyl)phenyl)propanoic acid, 95%, 100mg

2,3,5,6-tetraaminocyclohexa-2,5-diene-1,4-dione, 97%, 250mg

Methyl 2-(diethoxyphosphoryl)acetate, 95.0%, 1kg

5-(Morpholine-4-sulfonyl)-2-(piperidin-1-yl)benzoic acid, 98%, 250mg

2-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-2-{[(9h-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid, 98+%, 1g

1-Benzyl-1,4-dihydronicotinamide>95.0%(HPLC)(N)5g

2-Butyl-5-methyl-2 H -pyrazol-3-ylamine, 95.0%, 50g

Hexyl Ether>98.0%(GC)25mL

ETHYL 3-AMINO-6-METHYLPICOLINATE, 95.0%, 1g

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95.0%, 500mg